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Background: In the elderly, physical activity (PA) enhances cognitive performances,
increases brain plasticity and improves brain health. The neurotrophic hypothesis is that
the release of brain-derived neurotrophic factor (BDNF), which is implicated in brain
plasticity and cognition, is triggered by PA because motoneurons secrete BDNF into
the bloodstream during exercise. Individual differences in cognitive performance may
be explained by individual differences in genetic predisposition. A single nucleotide
polymorphism on the BDNF gene, BDNFVal66Met, affects activity-dependent BDNF
secretion. This study investigated the influence of the BDNFVal66Met polymorphism on
the relationship between PA and controlled inhibition performance in older adults.
Methods: A total of 114 healthy elderly volunteers (mean age = 71.53 years old)
were evaluated. Participants were genotyped for the BDNFVal66Met polymorphism. We
evaluated inhibitory performance using choice reaction times (RT) and error rates from
a Simon-like task and estimated their PA using two self-reported questionnaires. We
established four groups according to PA level (active vs. inactive) and BDNFVal66Met
genotype (Met carriers vs. Val-homozygous). The results were analyzed using ANOVA
and ANCOVA, including age, gender and body mass index as covariates.
Results: The BDNFVal66Met polymorphism interacted with PA on controlled inhibition
performance. More specifically, inactive Val-homozygous participants exhibited a lower
inhibition performance than active Val homozygotes and inactive Met carriers; the former
had a higher error rate without differences in RT.
Conclusion: Differences between individuals on inhibitory performance may be partially
understood by the interaction between genetic influence in BDNF secretion and PA
level. The results of this study clearly support the neurotrophic hypothesis that BDNF
synthesis is an important mechanism underlying the influence of physical activity on
brain structure and functions.
Keywords: BDNF gene, physical activity, aging, executive functions, controlled inhibition, genetic polymorphism,
reaction time
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INTRODUCTION
Substantial research demonstrated that regular physical activity
(PA) exerts beneficial effects on cognitive performance in the
elderly (Kirk-Sanchez and McGough, 2014; Erickson et al.,
2015; Prakash et al., 2015). More specifically, it has been
shown that PA exerts a larger positive influence on tasks
mainly tapping executive functions than other tasks focusing
on speed of information processing or visuospatial processing
(Colcombe and Kramer, 2003). Different authors suggested
that executive functions are not a unitary function but rather
an umbrella of inter-correlated functions such as controlled
inhibition, cognitive flexibility and updating of working memory
(Duncan et al., 1997; Miyake et al., 2000). Within this diversity
of executive functions, controlled inhibition seems to benefit
more selectively from PA than the other executive functions
(Smiley-Oyen et al., 2008; Boucard et al., 2012; Predovan et al.,
2012; Gajewski and Falkenstein, 2016). Controlled inhibition
is the capacity to suppress irrelevant information or prepotent
responses, and it plays a core role in the executive functions
construct (Miyake et al., 2000). Deterioration in inhibitory
processes may play a central role in age-related declines in several
different cognitive functions (Hasher and Zacks, 1988). However,
some recent meta-analyses failed to demonstrate consistent and
reliable benefits of PA on executive functions (Angevaren et al.,
2008; Kelly et al., 2014), despite the apparent consensus of
the positive effects of PA on cognitive functioning in elderly
populations. Differences in study designs, training programs
or the methodology used to analyze the principal outcomes
primarily explain these inconsistent results (Audiffren et al.,
2011). Another way explaining these discrepancies is the variety
of participant characteristics in these studies, such as gender and
age (see Fagot et al., 2017), or education level. The genetic profile
is also an important factor that influences cognition, but it has
received very little attention.
Several brain molecular and cellular mechanisms, such as the
synthesis of neurotrophic proteins, progressively change during
the aging process (Grady, 2008). Brain-derived neurotrophic
factor (BDNF) is one of the main proteins involved in cerebral
functioning (Neeper et al., 1995; Adlard et al., 2005; Snigdha et al.,
2014), and its secretion decreases during aging (Pang and Lu,
2004). BDNF release is associated with the genetic profile of its
gene. In other respect, regular PA was also associated with higher
concentration of BDNF in the brain and enhancement of brain
plasticity (Cotman and Berchtold, 2002; Cotman et al., 2007).
A single nucleotide polymorphism in the BDNF gene,
BDNFVal66Met, affects BDNF secretion, and it may be involved
in the deleterious effect of brain aging (Miyajima et al., 2008).
The Met allele of the BDNFVal66Met polymorphism is present
on one or two gene copies in 30% of the United States population
(Shimizu et al., 2004). The deleterious effect of this Met allele
reduces BDNF secretion in response to neuronal stimulation
in adults (Egan et al., 2003; Kleim et al., 2006). When brain
BDNF levels decrease, a lower cognitive performance can thus
be expected. As mentioned just earlier, a lower level of brain
BDNF can be observed in sedentary people by comparison
to active people (Szuhany et al., 2015; Dinoff et al., 2016)
and/or in people with two Met alleles at codon 66 of the
BDNF gene. The examination of a possible interaction between
PA and BDNF polymorphism on different cognitive functions
declining with aging, and more particularly executive functions,
is then particularly important. For instance, it can be expected
that the positive effect of PA on executive functions may
counteract the negative effect of the BDNF polymorphism Met
allele (Raz et al., 2009). In this perspective, several authors
examined the interaction between BDNFVal66Met and PA in
elderly participants on cognitive performance, brain volume
and/or cerebral plasticity (Kim et al., 2011; Erickson et al., 2013;
Brown et al., 2014; Canivet et al., 2015; Crispim Nascimento
et al., 2015; Thibeau et al., 2016). Only the last study of Thibeau
et al. (2016) tested this interaction on executive functions. These
authors demonstrated in a longitudinal study that Val carriers
without PA exhibited poorer executive functions performance at
age 75 than their peers with higher PA levels. In contrast, the
level of PA did not affect executive functions performance in Met-
heterozygous. It is interesting to note that they used four tasks
tapping executive functions including two tasks well-known to
involve controlled inhibition, the Stroop task and the Hayling
sentence completion test. The results observed by Thibeau et al.
(2016) converge with those of a previous study conducted
by our group (Canivet et al., 2015), which demonstrated that
only Val-homozygous older adults benefited from regular PA
and exhibited better episodic memory performance compared
to their Val-homozygous inactive counterparts. However, a
same polymorphism can lead to notable variations in protein
secretion in different ethnic groups (see Tsai et al., 2008).
Consequently, a replication of Thibeau et al. (2016) data
in a different population is important to generalize the
results.
The present study used the same pool of participants aged
55 years and older than the study of Canivet et al. (2015)
and examined the interaction between PA and the BDNF
polymorphism on controlled inhibition performance using a
modified Simon-like reaction time task. Participants in Simon-
like tasks respond to a relevant stimulus feature (e.g., an arrow),
and the position of the stimulus is always irrelevant (Verbruggen
et al., 2005). There is a dimensional overlap between the irrelevant
stimulus feature, i.e., the position of the stimulus, and the
response set, i.e., the direction of the arrow in the example.
When the stimulus position corresponds with the response side
(e.g., left key press to a stimulus that is presented on the left of
the screen), the trial is considered congruent, and the responses
are typically faster than incongruent trials, where there is a
mismatch between the stimulus position and response side. The
dual-route model (e.g., Kornblum et al., 1990) suggests that
the relevant stimulus feature (e.g., the direction of the arrow)
is processed via a controlled route and activates the correct
response, and a second response code is activated by the position
of the stimulus via an automatic route. Ridderinkhof (2002)
proposed that the automatic activation of the incorrect response
is selectively suppressed by a central active inhibitory mechanism
that requires time and may explain why participants respond
slower on incongruent trials. The performance of older adults
is consistently impaired in this type of task, but PA potentially
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reduces this impairment. It is also important to note that there
is a problem of task impurity related to the measurement
of the effectiveness and/or efficiency of a specific cognitive
process (Burgess, 1997; Phillips, 1997). Generally, a cognitive
task well-known to tap a cognitive process such as executive
functions, or more specifically controlled inhibition, also involves
other non-executive cognitive processes, for instance semantic
memory. Consequently, a low performance observed in a specific
task can be due to the executive component of the task and/or
to the non-executive component of the task. The impurity
of cognitive tasks may explain, on the one hand, the weak
correlation between tasks well-known to tap executive functions
(Miyake and Shah, 1999) and, on the other hand, the weak
reliability test–retest of these same tasks (Denckla, 1996). It is
recommended to use several tasks tapping the same cognitive
function in the same study in order to avoid this problem of
impurity. Another approach is to replicate the results using
one or more tasks tapping the same cognitive process than the
replicated study; this was the approach chosen in the present
study.
The results of Canivet et al. (2015) and Thibeau et al. (2016)
suggest a PA × BDNF polymorphism interaction on cognitive
performance such as the effect of PA on controlled inhibition
will be significant only for the Val-homozygous carriers, and Met
carriers will not be affected by PA. In this perspective, the present
cross-sectional study aims to replicate the results obtained by
Thibeau et al. (2016) on controlled inhibition but using a different
task tapping the controlled inhibition function in a sample of
French participants.
MATERIALS AND METHODS
Study
Data were collected within the “PRAUSE” survey conducted in
Poitou-Charentes, France from 2011 to 2013 (Canivet et al.,
2015). A total of 466 retired volunteers aged 55 years and older
(mean age = 75.72; SD = 9.84) were included in the survey.
They have been contacted through a sampling frame of 3716
address records from the census surveys conducted by the French
Institute of Statistics and Economical Studies (Institut national de
la statistique et des études économiques – INSEE). This master-
sample for regional extensions was very representative of the
senior population of Poitou-Charentes (France). The inclusion
criteria of the study were: (1) to be 55 years old or more,
(2) to live in Poitou-Charentes (France), (3) to be retired, in
a situation of long-term unemployment, long-term sick leave
or never engaged in the paid labor force. Non-native French
speakers and people institutionalized in an Establishment of
Accommodation for Dependent Old Persons (EHPAD) were
excluded from participation. The survey was conducted at home
and involved three sessions of 1.5–2 h each. A battery of cognitive
tests and questionnaires was administered during these three
sessions. Buccal swabs were taken during session 1 and the
reaction time task was administered in session 3. There was an
attrition rate of 39% between sessions 1 and 2, and 30% between
sessions 2 and 3.
Participants
A total of 114 participants (mean age = 71.53 years; SD = 9.13)
of the 466 volunteers were included in the current analyses
because they completed all required tests and questionnaires
to test our hypothesis (see Figure 1). We selected only active
participants with body mass index (BMI) less than 35 to increase
the likelihood of observing a significant effect of PA on cognitive
performance (Nguyen et al., 2014).
This study was carried out in accordance with the
recommendations of “Conseil National de l’Information
Statistique” (CNIS) [French National Council of Statistical
Information] and “Commission Nationale de l’Informatique
et des Libertés” (CNIL) [French National Commission on
Informatics and Liberty] with written informed consent from
all subjects. All subjects gave written informed consent in
accordance with the Declaration of Helsinki. The protocol was
approved by two national ethics committees: (1) the survey
received the “general interest and statistical quality” label
from the CNIS (Visa n◦2012X907RG); and (2) authorization
n◦1593815 from the CNIS (deliberation n◦2012-375).
Cognitive Assessments
Mini Mental State Examination
Global cognitive functioning was evaluated during the first
session using the MMSE. Cognitive impairment (exclusion
criterion) was defined as a score below 24 (Folstein et al., 1975).
Only participants with an MMSE score equal to or higher than 24
were included in the study.
Controlled Inhibition
Inhibitory performance was assessed using a computerized
reaction time task. The task was constructed and administered
using E-Prime 2.0 software (Psychology Software Tools,
Pittsburgh, PA, United States). The stimuli were arrows that
appeared on the right or left of the computer screen. Participants
responded as accurately and as rapidly as possible using a button
press with a millisecond precision (Serial Response BoxTM,
Psychology software Tools, Pittsburgh, PA, United States)
according to the direction indicated by the head of the arrow. If
the arrow pointed to the right, the participant had to press the
right key of the Serial Response Box with the right forefinger
and if the arrow pointed to the left, he/she had to press the left
key with the left forefinger (see Figure 2). On each trials, the
following sequence of events occurred: a black fixation point
appeared at the center of the screen for a mean duration of
500 ms, varying randomly between 300 and 700 ms with a
100 ms incremental step. The stimulus (arrow pointing to the
left or right) appeared on the right or left side of the screen
and remained until the onset of the participant’s response
(see Figure 2). Afterward, the screen went blank for 1000 ms
following the onset of the participant’ response or after a
maximum of 2500 ms. There was a distance of approximatively
750 mm between the screen and the eyes of the participant.
The stimulus (the arrow) was 20 mm wide and located at
137 mm from the center of the monitor. Measures of inhibition
were obtained in one block of 300 trials, where 200 congruent
trials and 100 incongruent trials were randomly presented.
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FIGURE 1 | Flow chart describing the selection process of participants. MMSE, mini mental state examination; BDNFVal66Met, brain-derived neurotrophic factor
gene polymorphism; PA, level of physical activity.
Congruent trials were trials where the arrow pointed to the
right (→) and appeared on the right of the screen or pointed
to the left (←) when appearing on the left of the screen.
Incongruent trials were trials where the arrow pointed to the
opposite side of its spatial location on the screen. We used
mean reaction time (RT, in ms) data and error rate (in %)
for incongruent and congruent trials as dependent variables.
Figure 2 described the experimental setup of the reaction time
task.
Genotyping
DNA was extracted from buccal cells using a QIAamp DNA
Blood Mini Kit (QIAGEN GmbH - QIAGEN Strasse 1.
40724 Hilden, Germany) according to the manufacturer’s
protocol. SNPs were genotyped using polymerase chain reaction
and restriction fragment length polymorphism (PCR-RFLP)
analysis. PCR amplification of the BDNF polymorphism
Val66Met (rs6265) was performed using the forward
primer 5′-GCCTACCCAGGTGTGCGG-3′ and the reverse
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FIGURE 2 | Setup of the reaction time task. (A) The direction of the arrow (toward the right side of the screen) is congruent with the location of the arrow (in the right
side of the screen); the participant responds to the arrow by pressing the right key. (B) The direction of the arrow (toward the right side of the screen) in incongruent
with the location of the arrow (in the left side of the screen); the participant responds to the arrow by pressing the right key. Congruent and incongruent stimuli had
the same probability of occurrence in the right and the left side of the screen.
fluorescent primer 5′-FAM-GAGGAGGCTCCAAAGGCAC-3′.
PCR products were digested using the restriction enzyme
Hsp92II (Promega Corporation – 2800 Woods Hollow Road.
Madison, WI 537 11-5399, United States) and resolved using
capillary electrophoresis in an ABI PRISM 3130 DNA Genetic
Analyzer (Applied Biosystem by Life Technologie, Thermo Fisher
Scientific – 168 Third Avenue, Waltham, MA, United States
02451).
The allelic frequency was estimated using Hardy Weinberg
equilibrium and the khi2 test. The distribution of genotypes
in the sample did not differ from the Hardy–Weinberg
equilibrium (p = 0.65). Genetic data were analyzed using a
dominance model that combined Met carriers into a single
group (Met/Met + Val/Met) because the Val/Met and Met/Met
genotypes were previously associated with decreased cognitive
performance compared to Val-homozygous genotypes (Miyajima
et al., 2008; Raz et al., 2009; Lim et al., 2014) and the low presence
of the Met/Met genotype (Shimizu et al., 2004) in the population.
Physical Activity
The Historical Leisure Activity Questionnaire (HLAQ)
The level of current PA was evaluated during the second
session using the HLAQ (Kriska et al., 1988). This validated
questionnaire was used to assess the history of PA weighted
by their relative intensity. Participants were asked to report the
frequency, type, intensity, and hours of PA performed during the
present year. We used the Compendium of Physical Activities
Tracking Guide 2011 (Ainsworth et al., 2011) to obtain a specific
metabolic equivalent (MET) for each PA. We calculated the
average energy expenditure (Mets-h/week) for each participant
using the HLAQ data and the compendium. We classified the
participants according to their METs-h/week following World
Health Organization (WHO) recommendations: participants
with greater than or equal to 7.5 METs-h/week were in the active
group and participants with lower than 7.5 METs-h/week were in
the inactive group.
The NASA/JSC Physical Activity Scale
All participants were asked to rate their current regular weekly
physical practices during the first session to identify their PA level
on a score from 0 to 7 using the NASA/JSC Physical Activity
Scale (Jackson et al., 1990). We used these data to confirm the
participant’s PA level in cases they were near the 7.5 METs-
h/week (±0.50). Seventy-eight participants were evaluated using
this verification method. They were considered active if their
NASA/JSC PA score was strictly higher than 3. Participants who
scored level 4 or above practiced regularly intensive PA at least
3 h per week (three participants). Participants were classified as
inactive if their NASA/JSC PA score was strictly lower than 3 (one
participant).
Group Constituents
We established four independent groups of participants
according to their PA level (above or below 7.5 METs-h/week)
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TABLE 1 | Demographic characteristics of participants.
Active Inactive Total Effects of
PA and BDNF
Groups Met carriers Val/Val Met carriers Val/Val
Participants (n) 34 30 22 28 114
Age (years) 70,85 (8.48) 68.98 (8.95) 71.83 (9.19) 74.84 (9.47) 71.53 (9.13) PA∗
Gender (M/F) 22/13 15/15 11/11 8/20 56/58 PA∗, BDNF∗
Visual acuity (N/W) 27/7 25/5 16/6 22/6 90/24 NS
BMI (kg/m2) 26.01 (3.73) 27.23 (4.37) 28.94 (4.17) 28.92 (4.67) 27.57 (4.35) PA∗
MMSE (0–30) 28.06 (1.58) 28.40 (1.48) 28.59 (1.18) 27.71 (2.05) 28.17 (1.63) NS
Depression (0–30) 5.82 (4.85) 6.93 (5.40) 7.59 (5.40) 7.32 (4.39) 6.82 (4.98) NS
Education level (1–20) 10.09 (3.52) 11.60 (3.64) 11.18 (4.02) 10.14 (3.61) 10.71 (3.69) NS
Hour/week of PA 9.35 (5.59) 11.97 (8.76) 0.17 (0.42) 0.55 (0.70) 6.16 (7.48) PA∗
Mets-h/week of PA 48.53 (31.02) 62.20 (50.28) 0.61 (1.56) 2.24 (2.70) 31.78 (40.91) PA∗
Mean (± standard deviation); M, male; F, female; N, normal vision with or without correction; W, weakened vision even with correction; BMI, Body Mass Index; PA∗,
significant main effect of PA; BDNF∗, significant main effect of BDNF polymorphism; NS, no effect of PA or BDNF.
and BDNFVal66Met profile (Met Carriers vs. Val-homozygous)
(see Table 1).
Geriatric Depression Scale (GDS)
The French version of the GDS (Bourque et al., 1990) was
used in order to assess the level of participants’ depressive
symptomatology (maximum = 30; Yesavage et al., 1983).
Depression was evaluated because previous studies demonstrated
an interaction between BDNF polymorphism and PA on
depression (Bryan et al., 2007; Mata et al., 2010; Erickson et al.,
2012). Brink et al. (1982) suggested that depression scores from
1 to 10 be considered normal, while depression score ≥ 11 are
indicative of possible depression.
Education Level
Education level contributes to cognitive reserves (Farfel
et al., 2013; Stern, 2013), and it strongly influences cognitive
performance in older adults. Education level was evaluated as
the number of years of formal education from the 1st year of
elementary school (level 1) to the 3rd year of a Ph.D. degree
(level 20) (1–20 years).
Statistical Analysis
The assumption of data normality and homogeneity was assessed
using Lilliefors and Levene tests, respectively. Error rates were
not normally distributed, and these data were arcsine square-root
transformed. We performed separate analyses of variance
(ANOVAs) on mean RT and transformed error rates using a
general linear model, with PA level (active vs. inactive) and BDNF
polymorphism (Met carriers vs. Val-homozygous) as between-
subjects factors and trial type (congruent vs. incongruent) as a
within-subject factor. Analyses of covariance (ANCOVAs) were
performed on the same measures, with gender, age and BMI
as covariates because these factors were significantly associated
with PA or BDNF polymorphism (see Table 1). The level of
significance was set at p < 0.05, and partial estimated effect
sizes (η2p) are reported for significant results. Post hoc mean
comparisons were performed using Bonferroni corrections for
multiple comparisons. All statistical and power analyses were
conducted with Statistica 7.1 package (Statsoft France, 2016).
RESULTS
The ANOVA on RT data revealed no main effect of PA
[F(1,110) = 2.23, p > 0.13] or BDNF polymorphism
[F(1,110) = 0.46, p > 0.50]. There was a significant effect of trial
type. Congruent trials produced shorter RTs (M = 614.97 ms;
SD = 11.60 ms) than incongruent trials (M = 770.26 ms;
SD = 16.41 ms) [F(1,110) = 314.45; p < 0.05; η2p = 0.77].
The PA × BDNF polymorphism × trial type interaction
was marginally significant [F(1,110) = 3.184, p = 0.08],
which suggests that only Val-homozygous active participants
exhibited shorter RT on incongruent trials compared to their
Val-homozygous inactive counterparts. However, the results of
the ANCOVA revealed that this interaction was not significant
when controlling for age, gender and BMI [F(1,102) = 1.88,
p > 0.18]. A last ANCOVA on RT data with Visual acuity and
Depression as additional covariates, pointed out no significant
effect of Visual acuity [F(1,100) = 0.30; p > 0.58] and a marginal
effect of Depression [F(1,100)= 3.51; p= 0.06] on RT (Table 2).
The ANOVA on error rates revealed no main effect of
PA [F(1,110) = 2.90, p > 0.09] or BDNF polymorphism
[F(1,110)= 1.49, p> 0.22]. The effect of trial type was significant
[F(1,110) = 337.34; p < 0.05; η2p = 0.75]. Participants made
fewer errors for congruent trials (M = 1.24%; SD = 0.24%) than
TABLE 2 | Mean RT (± standard deviation) for congruent and incongruent trials as
a function of group of participants.
RT congruent trials RT incongruent trials
Active Met carriers 601.27 (104.10) 757.99 (172.32)
Inactive Met carriers 610.82 (144.43) 756.48 (181.19)
Active Val/Val 594.48 (109.76) 728.29 (155.03)
Inactive Val/Val 649.04 (138.15) 828.59 (184.18)
Mean (± standard deviation); RT, reaction time (in ms).
Frontiers in Human Neuroscience | www.frontiersin.org 6 November 2017 | Volume 11 | Article 541
fnhum-11-00541 November 4, 2017 Time: 16:31 # 7
Canivet et al. BDNF Polymorphism and Physical Activity
FIGURE 3 | Interaction between BDNF polymorphism (Met carriers vs.
Val/Val) and Physical Activity (active vs. inactive) on average error rate (in %) in
congruent and incongruent trials. Errors bars represent standard deviation.
∗p < 0.01.
incongruent trials (M = 7.61%; SD = 0.60%). The PA × BDNF
polymorphism × trial type interaction reached significance
[F(1,110) = 9.75, p < 0.05, η2p = 0.08]. The results of the
ANCOVA revealed that this interaction remained significant after
controlling for age, gender and BMI [F(1,102) = 6.72, p < 0.05,
η2p = 0.06]. The statistical power of this interaction was 72.8%.
Post hoc analyses confirmed a significant difference in error rate
between Val/Val active and Val/Val inactive participants only for
the incongruent trials (p < 0.01) and a significant difference
between Val/Val inactive participants and Met carrier inactive
participants only for the incongruent trials (p < 0.01) (see
Figure 3). A last ANCOVA on error rates with Visual acuity and
Depression as additional covariates, pointed out no significant
effect of Visual acuity [F(1,100)= 0.25; p> 0.61] and a significant
effect of Depression [F(1,100) = 4.03; p < 0.05; η2p = 0.05].
The interaction between PA× BDNF polymorphism× trial type
remained significant despite controlling for these two additional
covariates [F(1,100)= 6.70; p < 0.05; η2p = 0.06].
DISCUSSION
This study examined the interaction between PA and the
BDNFVal66Met polymorphism on controlled inhibitory
performance in older adults. Our hypothesis was that PA would
interact with the Val allele on cognitive performance that
involved conflict monitoring and controlled inhibition (i.e.,
the incongruent trials in our experimental task). The classical
detrimental effect of no-dimensional overlap between the
direction and location of the stimuli (i.e., an arrow) was clearly
reproduced and demonstrated using RT and error rates. The
dual-route model states that incongruent trials require more
time to inhibit an automatic response, which leads to slower RT
and a higher percentage of errors because of the failure of the
inhibition process in some trials (Ridderinkhof, 2002). However,
we did not observe a clear significant interaction between PA
and polymorphisms on the average RT for trials that involved
controlled inhibition, but the interaction reached significance
on error rates. Specifically, the interaction demonstrated that
inactivity was associated with a significant increase in error
rate only for inactive Val-homozygous participants in the
incongruent condition. This interaction confirms that PA
modulates the relationship between the BDNF polymorphism
and controlled inhibition as measured using error rates for
incongruent trials. More precisely, it suggests that PA and
BDNF share a common neurophysiological mechanism that
influences controlled inhibition. The most plausible mechanism
that could play this role is the neurotrophic influence of BDNF
on prefrontal neurons. Both exercise and the Val allele of the
BDNF polymorphism increase the concentration of BDNF in the
brain (Cotman and Berchtold, 2002), consequently they must
interact at a structural and/or a functional level in some regions
of the brain, in this case prefrontal regions. Then, the interaction
between PA and BDNF polymorphism observed in the present
study gives a supplementary argument for the mediation role of
BDNF in the causal link between exercise and cognition.
In addition, the present results confirm and extend the results
obtained by Thibeau et al. (2016): inactive Val-homozygous
exhibited a poorer performance in controlled inhibition than
Met carriers and active Val homozygous. In the current study,
the degraded performance corresponded to a higher error rate
for incongruent trials in a Simon-like task. Thibeau et al. (2016)
observed very similar results using a Stroop task and a Hayling
sentence completion task. These two studies strongly suggest
that Val-homozygous individuals are more sensitive to PA level.
Inactivity seems very deleterious for Val-homozygous carriers.
Our results should be interpreted in light of the fact that physical
inactivity is a new phenomenon from an evolutionary point of
view. In contrast, the human genome is a product of a long
evolutionary process that has remained stable for 10.000 years
(Ratey and Loehr, 2011) and was built for hunters with periods of
intense PA balanced with periods of rest. Therefore, the wild type
Val/Val individuals could suffer more strongly from the effects of
a sedentary lifestyle than Met carriers.
But why Met carriers did not demonstrate any positive
effect of PA or negative effect of inactivity? The Met allele of
the BDNF polymorphism is generally viewed as a deleterious
variant because the Met allele reduces BDNF secretion in
response to neuronal stimulation (Egan et al., 2003; Kleim et al.,
2006). It is important to note that this deleterious effect of
the Met allele was not observed in the present experiment.
However, it could be hypothesized that BDNF secretion level
in Met carriers may not increase sufficiently in response to
regular PA, and the BDNF rate would remain too low to
benefit cognitive performance. Another mechanism may explain
the similar performance of controlled inhibition in active and
inactive Met carriers. Brown’s hypothesis (Brown et al., 2014)
is that the mature BDNF form is altered and inefficiently
binds to the BDNF receptor (TrkB) in BDNF Met carriers,
but the precursor form of BDNF (proBDNF) remains unaltered
in BDNF Met carriers. Unfortunately, proBDNF binds its
receptor (p75), and this link induces apoptosis. Therefore, Met
carriers with high levels of PA may undergo higher levels
of apoptotic changes in the brain because of the increasing
proBDNF levels. Increasing mature BDNF levels in response
to increased PA will not be sufficient to improve cognition.
Notably, the Caucasian population exhibits an approximately
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70% distribution of Val-homozygous (Shimizu et al., 2004).
Val-homozygous carriers in our population exhibited the greatest
benefit from the effects of PA, and 30% of the population (the
Met carriers) was less or not sensitive to the effects of PA
on controlled inhibition performance. Therefore, the cognitive
improvements reported by epidemiological and interventional
studies in primarily Western countries may be the result of the
high percentage of BDNF Val-homozygous allele carriers in this
population.
The present study emphasizes the interaction between BDNF
polymorphism and PA as a set of life habits that is recognized as
beneficial for brain health. We demonstrated that PA interacted
with BDNFVal66Met on controlled inhibitory performance.
Therefore, it is imperative to control for PA level to examine
the putative impact of the BDNFVal66Met polymorphism on
cognition in elderly populations.
Five main limitations may be noted. First, this study was
cross-sectional. The interpretation of these results as a causal
relationship between PA and cognition is limited by the
study design; cross-sectional study do not allow establishing
a causal relationship because better cognitive functioning
may promote an individual to engage in PA. Future studies
should use a randomized-controlled trial approach to determine
whether BDNF Val-homozygous carriers benefit from exercise
training programs. Second, the measure of PA was based
on the self-report of participants. These factors induce the
possibility of a biased reporting from the subjective perception
of participants about their PA level. However, the HLAQ
questionnaire and the NASA/JSC Physical Activity Scale are
widely recognized and well-validated instruments. Third, some
haplogroups may present protective or compensative effects
to certain alterations in protein secretion that is influenced
by a gene polymorphism. Tsai et al. (2008) demonstrated
that the Met allele protected Asian-type populations from the
deleterious effects of cognitive aging. It could be important to
conduct replication of the present study and Thibeau’s et al.
(2016) study in aging people from other ethnic group such
as Asian-type population. Fourth, only one gene related to
executive control was examined in the present study. However,
executive control and the association between physical fitness
and cognition are likely to be underpinned by many genes.
Several genes have been identified in addition to BDNF: DRD4,
DAT1, MAOA, COMT, APOE, each with a relatively small
effect (for a review, Goldberg and Weinberger, 2004). It could
be interesting to examine the synergistic and antagonistic
actions of these different genes on cognition, and focus on
those that share a common mechanism that may explain the
causal link between exercise and cognition. However, these
multi-polymorphisms studies require very large sample of
participants.
The present report showed a significant interaction between
PA and a BDNF gene polymorphism on controlled inhibitory
performance. These data demonstrated that the association
between PA and controlled inhibition was modulated by a
BDNF polymorphism. Inactivity appeared more deleterious for
Val-homozygous than Met carriers. This result improves our
understanding of the neurophysiological mechanisms underlying
the positive effect of PA on cognitive decline and provides brain
BDNF as a convincing modulating candidate in this relationship.
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